查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1926889

居家醫療監測和診斷市場（按產品類型、監測模式、行動裝置類型、連接方式、部署模式和最終用戶分類）－2026-2032年全球預測

Home-Care Monitoring & Diagnostics Market by Product Type, Monitoring Mode, Portability, Connectivity, Deployment Model, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年居家醫療監測和診斷市場價值為 76.1 億美元，預計到 2026 年將成長至 79.9 億美元，預計到 2032 年將達到 117.2 億美元，複合年成長率為 6.35%。

關鍵市場統計數據
基準年 2025 76.1億美元
預計年份：2026年 79.9億美元
預測年份 2032 117.2億美元
複合年成長率 (%) 6.35%

簡潔而引人入勝的引言闡述了智慧居家照護監測的迫切性，這種監測能夠協調臨床結果、患者自主性和系統效率。

居家照護監測和診斷技術正在重塑慢性病和急性病在傳統臨床環境之外的檢測、管理和追蹤方式。感測器設計、連接性和數據分析技術的進步，使臨床醫生能夠在確保數據真實性和臨床背景的同時，將護理服務延伸至患者家中。這種轉變支持以後續觀察為中心的模式，強調護理的連續性、及時干預和減少對間歇性就診的依賴，同時為優先考慮基於價值的醫療結果的醫療系統和支付方提高運營效率。

對正在重新定義居家照護監測產品設計和臨床整合的變革性技術、監管和護理服務轉變進行權威評估

近年來，居家醫療監測和診斷領域發生了突破性變革，正在重塑產品開發重點、籌資策略和臨床工作流程。首先，小型化和電池效率的提升使得設備能夠從臨床環境走向持久的家庭使用環境，從而擴展了連續監測和事件觸發監測的範圍。其次，無線連接和邊緣運算技術的進步降低了延遲和本地資料處理的負擔，使得即使在網路連接不穩定的情況下，也能實現更具彈性的解決方案。

對2025年關稅調整對居家醫療監測設備相關人員的供應鏈、籌資策略和採購計畫的影響進行重點分析

2025年的政策調整和貿易措施正對居家醫療監測醫療設備的供應鏈動態產生實際影響，迫使製造商和醫療系統重新調整其採購和生產策略。關稅變化加劇了零件和成品到岸成本的波動，導致圍繞近岸外包、供應商多元化和雙重採購安排的討論增多，以降低單一國家風險。這些討論不僅限於財務層面，也影響整個價值鏈的設計決策、零件選擇和供應商資格認證流程。

深度細分分析表明，產品類型、使用者環境、監控模式、便攜性、連接性和部署模式如何決定臨床和商業性路徑。

細分市場洞察揭示了產品架構、用戶場景、監測方法、便攜性、連接性和部署模式如何共同影響居家醫療監測市場的臨床效用和商業性差異化。按產品類型分類，該市場涵蓋心臟監測系統、血糖監測系統、神經系統監測系統、呼吸監測系統、體溫監測系統和生命徵象監測系統。心電圖監測進一步細分為心電圖監視器、心臟事件記錄器和心電圖監測，而心電圖解決方案又分為多通道和單通道。同時，血糖監測分為連續血糖監測儀和自我監測設備，後者進一步細分為間歇掃描式連續血糖監測和即時連續血糖監測。神經系統監測包括腦波監測儀和癲癇發作檢測監視器，而呼吸監測則涵蓋二氧化碳測量儀系統、呼吸頻率監視器和肺計量計。體溫監測包括電子體溫計、耳體溫計和額體溫計，而生命徵象系統包括血壓計、電子秤、多功能監視器和脈動式血氧監測儀系統。

區域性策略意義：將基礎建設、監管環境和支付方結構與全球市場的商業化和實施策略連結起來

區域趨勢持續影響著整個地區居家照護監測和診斷技術的應用、監管預期和商業化策略。在美洲，完善的醫療保健基礎設施、支付方積極參與基於價值的醫療模式以及成熟的分銷網路，為注重互通性和上市後證據的整合監測解決方案創造了有利條件。北美醫療保健機構越來越傾向於選擇能夠與電子健康記錄和護理管理平台整合的設備，並優先考慮那些能夠降低再入院率和改善患者報告結局的解決方案。

關鍵的競爭動態和公司層面的挑戰揭示了臨床證據、平台整合和協作式市場推廣模式如何塑造產業領導地位。

居家醫療監測和診斷領域的競爭地位取決於多種因素的綜合作用，包括設備性能、平台互通性、臨床證據和上市速度。主要企業正集中資源建構強大的生態系統，整合感測器、安全連接、分析功能和臨床工作流程，從而提供端到端的解決方案，而非僅僅提供單一設備。投資長期臨床研究和真實世界證據產生的企業，在爭取納入醫療服務路徑以及與支付方協商報銷條款時，將更具優勢。

加強產品、供應鏈和商業化領域韌性、臨床可靠性和綜合醫療服務能力的實用建議

為了在居家照護監測和診斷領域實現永續價值，產業領導者應優先考慮兼顧近期部署和長期韌性的策略行動。首先，投資於模組化產品架構，以便針對不同的臨床適應症和監管環境進行快速客製化，從而在保持核心互通性的同時加速市場准入。其次，加強與供應商的關係，並考慮雙重採購和區域製造夥伴關係，以降低政策引發的供應中斷風險，並提高對需求波動的應對力。

採用透明的多方法調查方法，結合專家訪談、文獻綜述和情境分析，檢驗市場區隔和策略洞察。

本研究採用結構化、多維度的研究方法，確保研究結果和解讀的準確性、相關性和透明度。研究人員從臨床、監管、供應鏈和支付方等各領域的專家收集了主要定性數據，以闡明技術趨勢和實施挑戰的背景。此外，研究人員還利用同行評審文獻、監管指導文件、臨床標準和已發表的資料進行二次研究，檢驗新出現的主題並確保產品分類的有效性。對這些資訊來源進行三角驗證，減少了研究偏差，並增強了所提出解讀的可信度。

策略結論強調了製定綜合性、循證解決方案和開展跨部門合作的必要性。

居家醫療監測和診斷技術的進步正朝著更深入的臨床整合、更廣泛的患者應用以及支持分散式醫療的先進平台生態系統發展。隨著技術的整合和醫療模式的演變，那些能夠將產品設計與臨床工作流程相契合、確保資料管治並創造可驗證成果的相關人員，將提供最具吸引力的價值提案。監管的清晰度和供應鏈的韌性之間的相互作用將繼續影響產品上市時間和長期競爭力，而報銷和基礎設施方面的區域差異則需要製定個性化的商業化策略。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章居家醫療監測和診斷市場（按產品類型分類）

  • 心臟監測系統
    • 心電圖監測儀
      • 多通道監視器
      • 單通道監視器
    • 心臟事件記錄器
    • 心電圖監測
  • 血糖監測系統
    • 連續血糖監測儀
      • 間歇掃描式動態血糖監測
      • 即時動態血糖監測
    • 自測血糖儀
  • 神經監測系統
    • 腦波監測儀
    • 癲癇發作偵測監測器
  • 呼吸監測系統
    • 二氧化碳測量儀系統
    • 呼吸頻率監測器
    • 肺計量計
  • 體溫監測系統
    • 數位體溫計
    • 耳體溫計
    • 額體溫計
  • 生命徵象監測系統
    • 血壓監測儀
    • 電子秤
    • 多功能顯示器
    • 脈動式血氧監測儀系統

第9章居家醫療監測與診斷市場（依監測模式分類）

  • 事件觸發式監控
  • 即時監控
    • 持續監測
    • 間歇性監測

第10章 行動端居家醫療監測與診斷市場

  • 攜帶式裝置
    • 手持顯示器
    • 桌面顯示器
  • 固定設備
  • 穿戴式裝置
    • 補丁監視器
    • 智慧服裝
    • 清單監視器

第11章居家醫療監測和診斷市場：連結性和性別

  • 有線連接
    • 乙太網路
    • USB
  • 無線連線
    • Bluetooth
    • 細胞
    • Wi-Fi

第12章居家醫療監測和診斷市場按部署模式分類

  • 基於雲端的
    • 私有雲端
    • 公共雲端
  • 本地部署

第13章居家醫療監測和診斷市場（按最終用戶分類）

  • 居家醫療機構
  • 病人
    • 慢性疾病患者
    • 老年人
    • 復健護理
  • 遠端醫療服務提供者
    • 院內監測
    • 第三人監控中心

第14章 按地區分類的居家醫療監測和診斷市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章居家醫療監測與診斷市場（依群體分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國居家醫療監測與診斷市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國居家醫療監測與診斷市場

第18章：中國居家醫療監測與診斷市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Dexcom, Inc.
  • Garmin Ltd.
  • GE HealthCare Technologies Inc.
  • iRhythm Technologies, Inc.
  • Koninklijke Philips NV
  • Masimo Corporation
  • Medtronic plc
  • Omron Healthcare Co., Ltd.
  • ResMed Inc.
  • Roche Diagnostics
Product Code: MRR-4F7A6D4FF35C

The Home-Care Monitoring & Diagnostics Market was valued at USD 7.61 billion in 2025 and is projected to grow to USD 7.99 billion in 2026, with a CAGR of 6.35%, reaching USD 11.72 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.61 billion
Estimated Year [2026] USD 7.99 billion
Forecast Year [2032] USD 11.72 billion
CAGR (%) 6.35%

A concise and compelling introduction that frames the urgent need for intelligent home-care monitoring, aligning clinical outcomes with patient autonomy and system efficiency

Home-care monitoring and diagnostics are reshaping how chronic and acute conditions are detected, managed, and followed up outside traditional clinical settings. Advances in sensor design, connectivity, and data analytics enable clinicians to extend the care continuum into patients' homes while preserving data fidelity and clinical context. This shift supports a patient-centered model that emphasizes continuous care, timely interventions, and reduced dependency on episodic hospital visits, and it creates operational efficiencies for health systems and payers that prioritize value-based outcomes.

As applications broaden, from cardiac rhythm surveillance to glucose sensing and respiratory assessment, stakeholders must navigate an evolving ecosystem of devices, platforms, and service models. Interoperability, regulatory clarity, and reimbursement alignment are emerging as critical enablers of scaled deployment. At the same time, patient acceptance hinges on ease of use, privacy assurances, and demonstrable improvements in quality of life. In this dynamic environment, this introduction outlines the fundamental tensions and opportunities that leaders must reconcile to realize the clinical and commercial potential of home-care monitoring and diagnostic solutions.

An authoritative assessment of the transformative technological, regulatory, and care delivery shifts that are redefining product design and clinical integration in home-care monitoring

Recent years have produced transformative shifts in the home-care monitoring and diagnostics landscape that are altering product development priorities, procurement strategies, and clinical workflows. First, miniaturization and improved battery efficiency have enabled devices to move from clinical settings into durable home use, thereby expanding the scope of continuous and event-triggered monitoring. Second, advances in wireless connectivity and edge computing have reduced latency and local data processing burdens, allowing for more resilient solutions that operate even with intermittent network availability.

Third, regulatory agencies have begun to provide clearer pathways for device approval and postmarket surveillance, which has accelerated commercial pathways while raising expectations for clinical evidence. Fourth, the rise of hybrid care models-combining telehealth with in-person care-has created new integration points where monitoring devices feed into remote care management platforms. Finally, a broader emphasis on patient experience and equity requires vendors to design for diverse user populations and to consider accessibility from the earliest stages of product design. Together, these trends are creating an environment in which rapid innovation coexists with heightened demands for reliability, security, and demonstrable clinical value.

A focused analysis of how 2025 tariff adjustments are reshaping supply chains, sourcing strategies, and procurement planning for home-care monitoring device stakeholders

Policy adjustments and trade actions in 2025 are exerting tangible effects on the supply chain dynamics for medical devices destined for home-care monitoring, prompting manufacturers and health systems to recalibrate sourcing and production strategies. Tariff changes have increased landed cost variability for components and finished goods, which in turn has fueled conversations about nearshoring, supplier diversification, and dual-sourcing arrangements to reduce exposure to single-country risks. These conversations are not merely financial; they influence design decisions, component selection, and vendor qualification processes across the value chain.

As firms respond, procurement timelines have lengthened in some cases while capital allocation decisions pivot toward supply chain resilience. Concurrently, the need to preserve device performance and regulatory compliance has limited the range of immediate substitutions for key components, creating pressure to invest in longer-term strategic partnerships with trusted suppliers. For clinical providers, these shifts have underscored the importance of transparent supplier information and lifecycle management to ensure continuity of patient monitoring services. In sum, tariff-driven dynamics in 2025 have accelerated supply chain modernization and strategic sourcing initiatives that are likely to persist beyond short-term policy cycles.

Deep segmentation insights showing how product type, user contexts, monitoring modes, portability, connectivity, and deployment models determine clinical and commercial pathways

Segment-level insights reveal how product architecture, user context, monitoring modality, portability, connectivity, and deployment model each shape clinical utility and commercial differentiation in the home-care monitoring market. Based on product type, the landscape spans cardiac monitoring systems, glucose monitoring systems, neurological monitoring systems, respiratory monitoring systems, temperature monitoring systems, and vital signs monitoring systems; cardiac monitoring further differentiates across ECG monitors, event monitors, and Holter monitors, with ECG solutions split into multi-channel and single-channel variants, while glucose monitoring divides into continuous glucose monitors and self-monitoring blood glucose devices, and continuous glucose monitoring further separates into intermittent scanning CGM and real-time CGM modalities. Neurological monitoring includes EEG monitors and seizure detection monitors, respiratory monitoring covers capnography systems, respiratory rate monitors, and spirometers, temperature monitoring encompasses digital, ear, and temporal thermometers, and vital signs systems include blood pressure monitors, digital weight scales, multiparameter monitors, and pulse oximeters.

Based on end user, differentiation arises across home healthcare agencies, patients, and telehealth service providers; patients themselves are segmented into chronic disease patients, elderly users, and post-acute care populations, while telehealth service provision bifurcates into hospital-based monitoring and third-party monitoring centers. In terms of monitoring mode, event-triggered solutions contrast with real-time monitoring, and real-time offerings further distinguish between continuous and intermittent monitoring approaches. Portability distinctions include portable devices, stationary devices, and wearable devices; portable solutions break down into handheld and tabletop monitors, and wearable devices encompass patch monitors, smart clothing, and wrist monitors. Connectivity modalities split between wired and wireless architectures, with wired options such as Ethernet and USB and wireless choices including Bluetooth, cellular, and Wi Fi. Finally, deployment model considerations separate cloud-based and on-premise implementations, with cloud environments differentiated into private and public configurations. These intersecting segmentation axes inform product requirements, clinical workflows, reimbursement pathways, and commercialization strategies.

Region-specific strategic implications that connect infrastructure readiness, regulatory environments, and payer landscapes to commercialization and adoption strategies across global markets

Regional dynamics continue to influence technology adoption, regulatory expectations, and commercialization strategies for home-care monitoring and diagnostics across large geographies. In the Americas, established healthcare infrastructure, active payer engagement with value-based models, and mature distribution networks create favorable conditions for integrated monitoring solutions that emphasize interoperability and postmarket evidence. North American providers increasingly seek devices that integrate with electronic health records and care management platforms, and they prioritize solutions that demonstrate improvements in readmission rates and patient-reported outcomes.

Across Europe, the Middle East and Africa, regulatory harmonization efforts and diverse payer landscapes create both opportunities and complexities; European adoption is often driven by national reimbursement decisions and cross-border clinical collaborations, while emerging markets in the region place a premium on affordability, durability, and ease of deployment in resource-constrained settings. In the Asia-Pacific region, rapid device innovation is paired with large and heterogeneous patient populations, creating strong demand for scalable telehealth and remote monitoring services. Local manufacturing initiatives and strategic partnerships in Asia-Pacific also shape supply dynamics and may accelerate time-to-market for regionally optimized products. Understanding these regional nuances is essential for companies seeking to align product design, market entry strategy, and regulatory planning with local clinical and commercial realities.

Key competitive dynamics and company-level imperatives revealing how clinical evidence, platform integration, and collaborative go-to-market models shape industry leadership

Competitive positioning within the home-care monitoring and diagnostics space is determined by a combination of device performance, platform interoperability, clinical evidence, and go-to-market agility. Leading firms have concentrated resources on building robust ecosystems that integrate sensors, secure connectivity, analytics, and clinician-facing workflows, which enables them to deliver end-to-end solutions rather than standalone devices. Companies that invest in longitudinal clinical studies and real-world evidence generation have an advantage when seeking inclusion within care pathways and when negotiating reimbursement arrangements with payers.

Elsewhere, nimble entrants focus on niche clinical applications or underserved patient segments, using design simplicity and cost-efficiency to gain early adoption in home healthcare agencies and post-acute settings. Strategic partnerships between device manufacturers, telehealth providers, and software vendors are increasingly common, as collaborative models accelerate deployment and reduce the burden on clinical staff. Intellectual property around sensing modalities, data security, and user experience remains an important differentiator, but sustainable leadership also depends on operational excellence in supply chain management and regulatory compliance. For stakeholders evaluating potential partners, the critical question is whether a competitor can demonstrate not only superior technology but also the capability to support longitudinal care delivery at scale.

Actionable recommendations for leaders to strengthen resilience, clinical credibility, and integrated care delivery capabilities across product, supply chain, and commercialization domains

Industry leaders should prioritize strategic actions that balance near-term deployment with longer-term resilience to capture sustainable value in home-care monitoring and diagnostics. First, invest in modular product architectures that allow rapid customization for different clinical indications and regulatory jurisdictions, enabling faster market entry while preserving core interoperability. Second, strengthen supplier relationships and consider dual-sourcing or regional manufacturing partnerships to reduce exposure to policy-driven supply disruptions and to improve responsiveness to demand variability.

Third, commit to rigorous clinical evidence generation through multicenter studies and real-world data initiatives that validate clinical outcomes, patient adherence, and economic value from the perspective of payers and providers. Fourth, design privacy-by-default data architectures and pursue recognized security certifications to build trust among clinicians and patients. Fifth, cultivate partnerships with telehealth providers and care management platforms to embed monitoring into clinical workflows and to create integrated service offerings. Finally, align commercialization plans with regional regulatory strategies and reimbursement pathways to accelerate uptake. By executing these measures in concert, leaders can move beyond product-centric approaches toward comprehensive care enablement, thereby enhancing both clinical impact and commercial viability.

A transparent and multi-method research methodology that integrates expert interviews, literature review, and scenario analysis to validate segmentation and strategic findings

This research employed a structured, multi-method approach to ensure accuracy, relevance, and transparency in its findings and interpretations. Primary qualitative inputs were gathered from subject-matter experts across clinical, regulatory, supply chain, and payer functions to contextualize technology trends and deployment challenges. Secondary research drew on peer-reviewed literature, regulatory guidance documents, clinical standards, and public filings to corroborate emerging themes and to validate product categorizations. Triangulation across these sources reduced bias and strengthened confidence in the interpretations presented.

Analytical frameworks emphasized segmentation by product type, end user, monitoring mode, portability, connectivity, and deployment model, with crosswalks to regional regulatory and reimbursement contexts. Where appropriate, scenario-based analysis was used to explore how supply chain disruptions and policy changes might influence strategic choices. Quality assurance procedures included expert review cycles and consistency checks against publicly available clinical evidence. This methodology ensured that conclusions rest on a balanced synthesis of empirical evidence, practitioner insight, and strategic analysis, enabling readers to rely on the report for informed decision-making.

A strategic conclusion emphasizing the imperative for integrated evidence-driven solutions and cross-functional alignment to deliver meaningful clinical and patient outcomes

The trajectory of home-care monitoring and diagnostics points toward deeper clinical integration, broader patient adoption, and more sophisticated platform ecosystems that support distributed care. As technologies converge and care models evolve, stakeholders who align product design with clinical workflows, secure data governance, and demonstrable outcomes will create the most compelling value propositions. The interplay between regulatory clarity and supply chain resilience will continue to shape time-to-market and long-term competitiveness, while regional differences in reimbursement and infrastructure will require tailored commercialization strategies.

Ultimately, success in this domain depends on the ability to translate device capability into meaningful improvements in clinical decision-making and patient experience. Achieving that translation demands cross-functional collaboration across engineering, clinical affairs, regulatory, and commercial teams. Organizations that embrace integrated solutions, invest in evidence generation, and prioritize secure, patient-centered design will not only capture market opportunities but also contribute to a more responsive and equitable continuum of care for patients managed at home.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Home-Care Monitoring & Diagnostics Market, by Product Type

  • 8.1. Cardiac Monitoring Systems
    • 8.1.1. ECG Monitors
      • 8.1.1.1. Multi Channel Monitors
      • 8.1.1.2. Single Channel Monitors
    • 8.1.2. Event Monitors
    • 8.1.3. Holter Monitors
  • 8.2. Glucose Monitoring Systems
    • 8.2.1. Continuous Glucose Monitors
      • 8.2.1.1. Intermittent Scanning CGM
      • 8.2.1.2. Real Time CGM
    • 8.2.2. Self Monitoring Blood Glucose Devices
  • 8.3. Neurological Monitoring Systems
    • 8.3.1. EEG Monitors
    • 8.3.2. Seizure Detection Monitors
  • 8.4. Respiratory Monitoring Systems
    • 8.4.1. Capnography Systems
    • 8.4.2. Respiratory Rate Monitors
    • 8.4.3. Spirometers
  • 8.5. Temperature Monitoring Systems
    • 8.5.1. Digital Thermometers
    • 8.5.2. Ear Thermometers
    • 8.5.3. Temporal Thermometers
  • 8.6. Vital Signs Monitoring Systems
    • 8.6.1. Blood Pressure Monitors
    • 8.6.2. Digital Weight Scales
    • 8.6.3. Multiparameter Monitors
    • 8.6.4. Pulse Oximeters

9. Home-Care Monitoring & Diagnostics Market, by Monitoring Mode

  • 9.1. Event Triggered Monitoring
  • 9.2. Real Time Monitoring
    • 9.2.1. Continuous Monitoring
    • 9.2.2. Intermittent Monitoring

10. Home-Care Monitoring & Diagnostics Market, by Portability

  • 10.1. Portable Devices
    • 10.1.1. Handheld Monitors
    • 10.1.2. Tabletop Monitors
  • 10.2. Stationary Devices
  • 10.3. Wearable Devices
    • 10.3.1. Patch Monitors
    • 10.3.2. Smart Clothing
    • 10.3.3. Wrist Monitors

11. Home-Care Monitoring & Diagnostics Market, by Connectivity

  • 11.1. Wired Connectivity
    • 11.1.1. Ethernet
    • 11.1.2. USB
  • 11.2. Wireless Connectivity
    • 11.2.1. Bluetooth
    • 11.2.2. Cellular
    • 11.2.3. Wi Fi

12. Home-Care Monitoring & Diagnostics Market, by Deployment Model

  • 12.1. Cloud Based
    • 12.1.1. Private Cloud
    • 12.1.2. Public Cloud
  • 12.2. On Premise

13. Home-Care Monitoring & Diagnostics Market, by End User

  • 13.1. Home Healthcare Agencies
  • 13.2. Patients
    • 13.2.1. Chronic Disease Patients
    • 13.2.2. Elderly
    • 13.2.3. Post Acute Care
  • 13.3. Telehealth Service Providers
    • 13.3.1. Hospital Based Monitoring
    • 13.3.2. Third Party Monitoring Centers

14. Home-Care Monitoring & Diagnostics Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Home-Care Monitoring & Diagnostics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Home-Care Monitoring & Diagnostics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Home-Care Monitoring & Diagnostics Market

18. China Home-Care Monitoring & Diagnostics Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Becton, Dickinson and Company
  • 19.7. Dexcom, Inc.
  • 19.8. Garmin Ltd.
  • 19.9. GE HealthCare Technologies Inc.
  • 19.10. iRhythm Technologies, Inc.
  • 19.11. Koninklijke Philips N.V.
  • 19.12. Masimo Corporation
  • 19.13. Medtronic plc
  • 19.14. Omron Healthcare Co., Ltd.
  • 19.15. ResMed Inc.
  • 19.16. Roche Diagnostics

LIST OF FIGURES

  • FIGURE 1. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MONITORING MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONNECTIVITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ECG MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ECG MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ECG MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ECG MONITORS, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MULTI CHANNEL MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MULTI CHANNEL MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MULTI CHANNEL MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SINGLE CHANNEL MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SINGLE CHANNEL MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SINGLE CHANNEL MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EVENT MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EVENT MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EVENT MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HOLTER MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HOLTER MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HOLTER MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY INTERMITTENT SCANNING CGM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY INTERMITTENT SCANNING CGM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY INTERMITTENT SCANNING CGM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REAL TIME CGM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REAL TIME CGM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REAL TIME CGM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY NEUROLOGICAL MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY NEUROLOGICAL MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY NEUROLOGICAL MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY NEUROLOGICAL MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EEG MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EEG MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EEG MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SEIZURE DETECTION MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SEIZURE DETECTION MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SEIZURE DETECTION MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY RESPIRATORY MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY RESPIRATORY MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY RESPIRATORY MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY RESPIRATORY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CAPNOGRAPHY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CAPNOGRAPHY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CAPNOGRAPHY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY RESPIRATORY RATE MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY RESPIRATORY RATE MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY RESPIRATORY RATE MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SPIROMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SPIROMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SPIROMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TEMPERATURE MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TEMPERATURE MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TEMPERATURE MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TEMPERATURE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DIGITAL THERMOMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DIGITAL THERMOMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DIGITAL THERMOMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EAR THERMOMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EAR THERMOMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EAR THERMOMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TEMPORAL THERMOMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TEMPORAL THERMOMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TEMPORAL THERMOMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY VITAL SIGNS MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY VITAL SIGNS MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY VITAL SIGNS MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY VITAL SIGNS MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DIGITAL WEIGHT SCALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DIGITAL WEIGHT SCALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DIGITAL WEIGHT SCALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MULTIPARAMETER MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MULTIPARAMETER MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MULTIPARAMETER MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PULSE OXIMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PULSE OXIMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PULSE OXIMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EVENT TRIGGERED MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EVENT TRIGGERED MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY EVENT TRIGGERED MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REAL TIME MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REAL TIME MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REAL TIME MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REAL TIME MONITORING, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONTINUOUS MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONTINUOUS MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONTINUOUS MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY INTERMITTENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY INTERMITTENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY INTERMITTENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HANDHELD MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HANDHELD MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HANDHELD MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TABLETOP MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TABLETOP MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TABLETOP MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY STATIONARY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY STATIONARY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY STATIONARY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WEARABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WEARABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PATCH MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PATCH MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PATCH MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SMART CLOTHING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SMART CLOTHING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SMART CLOTHING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WRIST MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WRIST MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WRIST MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRED CONNECTIVITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRED CONNECTIVITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRED CONNECTIVITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRED CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ETHERNET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ETHERNET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ETHERNET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY USB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY USB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY USB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRELESS CONNECTIVITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRELESS CONNECTIVITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRELESS CONNECTIVITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRELESS CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY BLUETOOTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY BLUETOOTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY BLUETOOTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CELLULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CELLULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CELLULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WI FI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WI FI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WI FI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CLOUD BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CLOUD BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CLOUD BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PRIVATE CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PRIVATE CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PUBLIC CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PUBLIC CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PATIENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CHRONIC DISEASE PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ELDERLY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ELDERLY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ELDERLY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY POST ACUTE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY POST ACUTE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY POST ACUTE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TELEHEALTH SERVICE PROVIDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TELEHEALTH SERVICE PROVIDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TELEHEALTH SERVICE PROVIDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TELEHEALTH SERVICE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HOSPITAL BASED MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HOSPITAL BASED MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY HOSPITAL BASED MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY THIRD PARTY MONITORING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY THIRD PARTY MONITORING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY THIRD PARTY MONITORING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 199. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 200. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 202. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ECG MONITORS, 2018-2032 (USD MILLION)
  • TABLE 203. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 204. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, 2018-2032 (USD MILLION)
  • TABLE 205. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY NEUROLOGICAL MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 206. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY RESPIRATORY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 207. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TEMPERATURE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 208. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY VITAL SIGNS MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 209. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 210. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REAL TIME MONITORING, 2018-2032 (USD MILLION)
  • TABLE 211. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 212. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 213. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 214. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 215. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRED CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 216. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRELESS CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 217. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 218. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 219. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 221. AMERICAS HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TELEHEALTH SERVICE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 222. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ECG MONITORS, 2018-2032 (USD MILLION)
  • TABLE 226. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, 2018-2032 (USD MILLION)
  • TABLE 228. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY NEUROLOGICAL MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY RESPIRATORY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 230. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TEMPERATURE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY VITAL SIGNS MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 232. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REAL TIME MONITORING, 2018-2032 (USD MILLION)
  • TABLE 234. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 236. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 238. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRED CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRELESS CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 240. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 242. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 244. NORTH AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TELEHEALTH SERVICE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CARDIAC MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 248. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY ECG MONITORS, 2018-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 250. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, 2018-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY NEUROLOGICAL MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 252. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY RESPIRATORY MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TEMPERATURE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 254. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY VITAL SIGNS MONITORING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY MONITORING MODE, 2018-2032 (USD MILLION)
  • TABLE 256. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY REAL TIME MONITORING, 2018-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 258. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PORTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 260. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRED CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 262. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY WIRELESS CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 264. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY CLOUD BASED, 2018-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY TELEHEALTH SERVICE PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA HOME-CARE MONITORING & DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (